This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
CLOZAPINE RISK EVALUATION AND MITIGATION STRATEGY (REMS) PROGRAM
PLEASE NOTE: All providers and pharmacies that prescribe or dispense clozapine must re-certify in the Clozapine Risk Evaluation and Mitigation Strategy (REMS) program by November 15, 2021. Prescribers and pharmacies that fail to re-certify cannot prescribe or dispense clozapine. To avoid disruption in care, prescribers must also re-enroll their patients in the Clozapine REMS program by November 15, 2021.To view the full memorandum, click here.
last updated: October 22, 2021
Speak To Someone In Your Community
Find someone in your neighborhood and in your language